Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Urologic Oncology, UT Health San Antonio/MD Anderson Mays Cancer Center, 7703 Floyd Curl Drive, Mail Code 7845, San Antonio, TX, 78229-3900, USA.
Int J Clin Oncol. 2022 Jun;27(6):1068-1076. doi: 10.1007/s10147-022-02153-5. Epub 2022 Mar 23.
BACKGROUND: A recently reported phase III randomized trial comparing open and minimally invasive hysterectomy showed significantly higher rates of local recurrence after minimally invasive surgery (MIS) for cervical cancer. This raised concerns regarding patterns of recurrences and survival after MIS in general. This study aims to determine the effect of MIS on all-cause mortality among patients undergoing radical nephrectomy for Stage I and II renal cell carcinoma (RCC). METHODS: We utilized the National Cancer Database to identify patients diagnosed with clinical stage I-II RCCs between 2010 and 2013. Patients for whom a laparoscopic or robotic radical nephrectomy was attempted were compared to patients who underwent open radical nephrectomy (ORN). Adjusted regression models with inverse probability propensity score weighting (IPW) were utilized to identify independent predictors of receiving MIS. All-cause mortality rates were compared using IPW survival functions and log-rank tests. Adjusted Cox proportional hazard models were fitted to determine independent predictors of OS. RESULTS: 27,642 patients were identified; 11,524 (41.7%) had MIS, while 16,118 (58.3%) had ORN. Kaplan-Meier survival curves in the IPW cohort showed significant OS advantage for patients who underwent MIS (p < 0.001). Furthermore, length of hospital stays (3 vs. 4 days), 30 day readmission rates (2.4 vs. 2.87%), 30 day (0.53 vs. 0.96%) and 90 day mortality rates (1.04 vs. 1.77%) were significantly higher in the ORN group (p < 0.001). CONCLUSIONS: MIS was associated with better OS outcomes compared to ORN for stage I and II RCC. In addition, MIS had lower post-operative readmission, 30- and 90 day mortality rates.
背景:最近报道的一项 III 期随机试验比较了开放式和微创子宫切除术,结果显示微创宫颈癌手术后局部复发率明显较高。这引起了人们对微创手术后复发模式和总体生存率的担忧。本研究旨在确定微创对接受根治性肾切除术的 I 期和 II 期肾细胞癌 (RCC) 患者全因死亡率的影响。
方法:我们利用国家癌症数据库,确定了 2010 年至 2013 年间被诊断为临床 I 期和 II 期 RCC 的患者。将尝试腹腔镜或机器人根治性肾切除术的患者与接受开放式根治性肾切除术 (ORN) 的患者进行比较。利用逆概率倾向评分加权 (IPW) 调整回归模型来确定接受微创的独立预测因素。使用 IPW 生存函数和对数秩检验比较全因死亡率。拟合调整后的 Cox 比例风险模型来确定 OS 的独立预测因素。
结果:共确定了 27642 名患者;11524 名 (41.7%) 接受了 MIS,16118 名 (58.3%) 接受了 ORN。IPW 队列中的 Kaplan-Meier 生存曲线显示接受 MIS 的患者具有显著的 OS 优势 (p<0.001)。此外,ORN 组的住院时间 (3 天比 4 天)、30 天再入院率 (2.4%比 2.87%)、30 天 (0.53%比 0.96%) 和 90 天死亡率 (1.04%比 1.77%)显著更高 (p<0.001)。
结论:与 ORN 相比,MIS 与 I 期和 II 期 RCC 的 OS 结果更好。此外,MIS 术后再入院、30 天和 90 天死亡率较低。
J Minim Invasive Gynecol. 2021-4
J Robot Surg. 2025-6-20
MedComm (2020). 2024-8-1
Clin Med Res. 2023-9
CA Cancer J Clin. 2021-1
J Natl Compr Canc Netw. 2020-6
N Engl J Med. 2018-10-31
N Engl J Med. 2018-10-31
World J Urol. 2017-5-5
Onco Targets Ther. 2016-10-31